Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
Autor/a
Data de publicació
2020-08-03ISSN
2053-3624
Resum
Objective: Primary percutaneous coronary intervention (P-PCI) has demonstrated its efficacy in patients with ST segment elevation myocardial infarction (STEMI). However, patients with STEMI ≥75 years receive less P-PCI than younger patients despite their higher in-hospital morbimortality. The objective of this analysis was to determine the effectiveness of P-PCI in patients with STEMI ≥75 years.
Methods: We included 979 patients with STEMI ≥75 years, from the ATención HOspitalaria del Síndrome coronario study, a registry of 8142 consecutive patients with acute coronary syndrome admitted at 31 Spanish hospitals in 2014-2016. We calculated a propensity score (PS) for the indication of P-PCI. Patients that received or not P-PCI were matched by PS. Using logistic regression, we compared the effectiveness of performing P-PCI versus non-performance for the composite primary event, which included death, reinfarction, acute pulmonary oedema or cardiogenic shock during hospitalisation.
Results: Of the included patients, 81.5 % received P-PCI. The matching provided two groups of 169 patients with and without P-PCI. Compared with its non-performance, P-PCI presented a composite event OR adjusted by PS of 0.55 (95% CI 0.34 to 0.89).
Conclusions: Receiving a P-PCI was significantly associated with a reduced risk of major intrahospital complications in patients with STEMI aged 75 years or older.
Tipus de document
Article
Versió del document
Versió publicada
Llengua
Anglès
Matèries (CDU)
616.1 - Patologia del sistema circulatori, dels vasos sanguinis. Trastorns cardiovasculars
Paraules clau
Pàgines
7
Publicat per
BMJ Open
Col·lecció
7; 2
Publicat a
Openheart
Citació
Fernández-Bergés, Daniel; Román-Degano, Irene; González Fernández, Reyes[et al.]. Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction. Openheart, 2020, 7(2), e001169. Disponible en <https://pubmed.ncbi.nlm.nih.gov/32747454/>. Fecha de acceso: 4 nov. 2025. DOI: 10.1136/openhrt-2019-001169.
Nota
Supported by: MARATO TV3 (081630), de AGAUR (2014SGR240); del Instituto de Salud Carlos III: Red de Investigación Cardiovascular RD12/0042 (Programa HERACLES); Red RedIAPP RD06/0018; CP12/03287; CIBER Epidemiología y Salud Pública; CIBERCV de enfermedades Cardiovasculares, Fondo Europeo de Desarrollo Regional (FEDER) (European Regional Development Funds -ERDF-); FIS CP12/03287, FIS 14/00449, FIS PI081327, FIS INTRASALUD PI1101801.
Aquest element apareix en la col·lecció o col·leccions següent(s)
- Ciències de la Salut [973]
Drets
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com https://creativecommons.org/licenses/by/4.0/


